Human prion diseases: from antibody screening to a standardized fast immunodiagnosis using automation
Nicolas Privat(Inserm), Stéphane Haı̈k(Broad Institute), Jean Laplanche(Université Paris Cité), Yveline Frobert(Commissariat à l'Énergie Atomique et aux Énergies Alternatives), Véronique Sazdovitch(Sorbonne Université), Jean‐Jacques Hauw(Académie Nationale de Médecine), Baptiste Faucheux(Inserm), Jacques Grassi(Universidade Federal do Espírito Santo), Isabelle Laffont-Proust(Centre National de la Recherche Scientifique)
Cited by 14
Related Papers
Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: an alternative to radioimmunoassay
|Analytical Chemistry|1985|707
Screening of 145 Anti-PrP Monoclonal Antibodies for Their Capacity to Inhibit PrPSc Replication in Infected Cells
|Journal of Biological Chemistry|2004|330
Demonstration of an inducible cyclooxygenase in human endothelial cells using antibodies raised against the carboxyl-terminal region of the cyclooxygenase-2.
|Journal of Biological Chemistry|1993|289
The mechanism of internalization of glycosylphosphatidylinositol‐anchored prion protein
|The EMBO Journal|2003|282
The Disintegrins ADAM10 and TACE Contribute to the Constitutive and Phorbol Ester-regulated Normal Cleavage of the Cellular Prion Protein
|Journal of Biological Chemistry|2001|281